Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)

NCT02332590 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

369

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Sarilumab
DRUG: Adalimumab
DRUG: Placebo (for sarilumab)
DRUG: Placebo (for adalimumab)

Sponsor

Sanofi

Collaborators

[object Object]